These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 16149049
1. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. Li X, Vradii D, Gutierrez S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Javed A. J Cell Biochem; 2005 Nov 01; 96(4):795-809. PubMed ID: 16149049 [Abstract] [Full Text] [Related]
2. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages. Himes SR, Cronau S, Mulford C, Hume DA. Oncogene; 2005 Aug 11; 24(34):5278-86. PubMed ID: 16007221 [Abstract] [Full Text] [Related]
3. Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes. Kwok JC, Perdomo J, Chong BH. J Cell Biochem; 2007 Aug 15; 101(6):1456-74. PubMed ID: 17340619 [Abstract] [Full Text] [Related]
4. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Kwon OH, Lee CK, Lee YI, Paik SG, Lee HJ. Biochem Biophys Res Commun; 2005 Sep 23; 335(2):437-46. PubMed ID: 16083856 [Abstract] [Full Text] [Related]
5. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene. van Dijk TB, Baltus B, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. J Immunol; 1999 Sep 01; 163(5):2674-80. PubMed ID: 10453008 [Abstract] [Full Text] [Related]
6. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD. Oncogene; 1995 Dec 21; 11(12):2667-74. PubMed ID: 8545124 [Abstract] [Full Text] [Related]
7. Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Oakford PC, James SR, Qadi A, West AC, Ray SN, Bert AG, Cockerill PN, Holloway AF. Leuk Res; 2010 Sep 21; 34(9):1203-13. PubMed ID: 20439113 [Abstract] [Full Text] [Related]
8. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE. Mol Cell Biol; 1998 Jul 21; 18(7):3915-25. PubMed ID: 9632776 [Abstract] [Full Text] [Related]
9. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites. Lennartsson A, Garwicz D, Lindmark A, Gullberg U. Gene; 2005 Aug 15; 356():193-202. PubMed ID: 16019164 [Abstract] [Full Text] [Related]
10. Regulation of CSF-1 receptor expression. Hume DA, Yue X, Ross IL, Favot P, Lichanska A, Ostrowski MC. Mol Reprod Dev; 1997 Jan 15; 46(1):46-52; discussion 52-3. PubMed ID: 8981363 [Abstract] [Full Text] [Related]
11. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z, Koschmieder S, Okuno Y, Dayaram T, Growney JD, Shivdasani RA, Gilliland DG, Speck NA, Nimer SD, Tenen DG. Nat Genet; 2008 Jan 15; 40(1):51-60. PubMed ID: 17994017 [Abstract] [Full Text] [Related]
12. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha. Gombart AF, Grewal J, Koeffler HP. J Leukoc Biol; 2007 Jun 15; 81(6):1535-47. PubMed ID: 17347301 [Abstract] [Full Text] [Related]
13. Essential role of C/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes. Iida S, Watanabe-Fukunaga R, Nagata S, Fukunaga R. Genes Cells; 2008 Apr 15; 13(4):313-27. PubMed ID: 18363963 [Abstract] [Full Text] [Related]
15. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene. Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP. Genes Chromosomes Cancer; 2003 Feb 15; 36(2):167-74. PubMed ID: 12508245 [Abstract] [Full Text] [Related]
16. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation. Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G. Exp Hematol; 2008 Nov 15; 36(11):1449-60. PubMed ID: 18687517 [Abstract] [Full Text] [Related]
17. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation. Dai HP, Xue YQ, Zhou JW, Li AP, Wu YF, Pan JL, Wang Y, Zhang J. Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1027-36. PubMed ID: 19760607 [Abstract] [Full Text] [Related]
18. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. Mol Cancer Res; 2005 Oct 15; 3(10):585-96. PubMed ID: 16254192 [Abstract] [Full Text] [Related]
19. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells. Wichmann C, Chen L, Heinrich M, Baus D, Pfitzner E, Zörnig M, Ottmann OG, Grez M. Cancer Res; 2007 Mar 01; 67(5):2280-9. PubMed ID: 17332359 [Abstract] [Full Text] [Related]
20. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells. Turner EC, Kinsella BT. J Mol Biol; 2009 Feb 27; 386(3):579-97. PubMed ID: 19118563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]